aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.130
-0.130 (-3.99%)
At close: Mar 28, 2025, 4:00 PM
3.187
+0.057 (1.83%)
After-hours: Mar 28, 2025, 7:59 PM EDT

aTyr Pharma Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 18.6, with a low estimate of 9.00 and a high estimate of 35. The average target predicts an increase of 494.25% from the current stock price of 3.13.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $9.00 $18.6 $16 $35
Change +187.54% +494.25% +411.18% +1018.2%

Analyst Ratings

The average analyst rating for aTyr Pharma stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 222222
Buy 222344
Hold 000000
Sell 000000
Strong Sell 000000
Total 444566

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,018.21% Mar 14, 2025
Leerink Partners
Leerink Partners
Buy
Initiates
$16
Buy Initiates $16 +411.18% Feb 18, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
n/a
Buy Initiates n/a n/a Jan 6, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,018.21% Dec 10, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$35
Strong Buy Reiterates $35 +1,018.21% Dec 3, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
3.50M
from 235.00K
Increased by 1,387.23%
Revenue Next Year
34.01M
from 3.50M
Increased by 873.22%
EPS This Year
-0.72
from -0.86
EPS Next Year
-0.53
from -0.72
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
10.46M-10.39M353.00K235.00K3.50M34.01M165.45M
Revenue Growth
2,377.49%---96.60%-33.43%1,387.23%873.22%386.42%
EPS
-1.77-1.77-1.60-0.94-0.86-0.72-0.530.15
EPS Growth
--------
Forward PE
-------20.80
No. Analysts -----131312
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 25.6M 123.9M 328.7M
Avg 3.5M 34.0M 165.5M
Low n/a n/a 19.6M

Revenue Growth

Revenue Growth 202520262027
High
10,814.0%
3,445.1%
866.2%
Avg
1,387.2%
873.2%
386.4%
Low - -
-42.4%

EPS Forecast

EPS 202520262027
High -0.60 0.29 1.08
Avg -0.72 -0.53 0.15
Low -0.90 -1.23 -0.81

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.